Heron Therapeutics
HRTX
#7355
Rank
โ‚น30.72 B
Marketcap
โ‚น201.70
Share price
-3.29%
Change (1 day)
-18.04%
Change (1 year)

Revenue for Heron Therapeutics (HRTX)

Revenue in 2024 (TTM): โ‚น12.13 Billion

According to Heron Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น12.38 Billion. an increase over the revenue in the year 2023 that were of โ‚น10.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Heron Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น12.37 B17.03%
2023 โ‚น10.57 B18.7%
2022 โ‚น8.90 B38.64%
2021 โ‚น6.42 B-0.86%
2020 โ‚น6.48 B-37.72%
2019 โ‚น10.40 B92.15%
2018 โ‚น5.41 B175.75%
2017 โ‚น1.96 B2160.27%
2016 โ‚น86.91 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A-100%
2011 โ‚น34.17 M-41.38%
2010 โ‚น58.29 M-0.36%
2009 โ‚น58.51 M229%
2008 โ‚น17.78 M
2005 โ‚น0.24 B3.66%
2004 โ‚น0.23 B6.01%
2003 โ‚น0.22 B-16.75%
2002 โ‚น0.26 B25.27%
2001 โ‚น0.21 B34.76%
2000 โ‚น0.15 B-82.92%
1999 โ‚น0.91 B9.27%
1998 โ‚น0.84 B17.7%
1997 โ‚น0.71 B5.83%
1996 โ‚น0.67 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น133.69 B 979.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น60.16 B 385.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.99 B-35.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น14.34 B 15.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.76 B-13.06%๐Ÿ‡บ๐Ÿ‡ธ USA